In contrast, the TET1-deficient A172 glioma cell line did not display significant migration at four hours after initializing migration, and at 12 hours migration was observed but significantly differently compared to the control cell line (Fig. 4D and Supplement Table 2). Here, TET1 is linked to central nervous system cancer.